CTMX 8-K 2026-07-27

CytomX Therapeutics, Inc. (CTMX) 8-K dated 2026-07-27 — accession 0001193125-26-316929. This URL is the filing, not the CTMX hub.

CytomX Therapeutics, Inc. (CTMX) is a biotechnology company listed on US.

CytomX Therapeutics, Inc. filed a 8-K on 2026-07-27. Accession 0001193125-26-316929.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTMX revenue for 2025-12-31 was $76.2M. Net income was -$17.4M. Revenue was down 44.8% from 2024-12-31 to 2025-12-31. CTMX currently screens at market cap $653.1M.

Not investment advice. The CTMX SEC hub lists recent forms. The stock page is the research view.